论文部分内容阅读
目的:探讨子宫内膜异位症患者分期与血清癌抗原125(CA125)水平的相关性,为早期临床诊断治疗子宫内膜异位症提供参考价值。方法:纳入该院在2010年6月~2014年6月期间收治的子宫内膜异位症患者80例。其分期根据美国生育学会(R-AFS)标准分期。采用化学发光法进行血清CA125的测定,严格按照试剂盒说明书标准操作,其中阳性判断以血清CA125≥35 U/ml作为标准。结果:Ⅰ期与Ⅱ期CA125检测值比较差异无统计学意义(P>0.05),Ⅲ期、Ⅳ期CA125检测值比较差异无统计学意义(P>0.05);Ⅲ期和Ⅳ期CA125检测值显著高于Ⅰ期和Ⅱ期,且差异具有统计学意义(P<0.05);Ⅰ期与Ⅱ期血清CA125阳性率对比差异无统计学意义(P>0.05);Ⅲ期与Ⅳ期血清CA125阳性率对比差异无统计学意义(P>0.05);Ⅲ期与Ⅳ期血清CA125阳性率显著高于Ⅰ期与Ⅱ期血清CA125阳性率,且差异具有统计学意义(P<0.05)。结论:子宫内膜异位症患者分期与血清CA125水平具有一定的相关性,Ⅲ期和Ⅳ期患者血清CA125具有较高的敏感性,血清CA125对子宫内膜异位症患者病情严重程度的评估具有重要参考价值。
Objective: To investigate the correlation between the staging of patients with endometriosis and the level of serum CA125 and to provide a reference value for the early clinical diagnosis and treatment of endometriosis. Methods: 80 cases of endometriosis admitted to our hospital from June 2010 to June 2014 were enrolled. The staging is based on the American Fertility Society (R-AFS) standard staging. Chemiluminescence method for the determination of serum CA125, in strict accordance with kit instructions manual operation, in which the positive judgment of serum CA125 ≥ 35 U / ml as a standard. Results: There was no significant difference between the detection of CA125 in stage Ⅰ and Ⅱ (P> 0.05), while there was no significant difference in the detection of CA125 between stage Ⅲ and stage Ⅳ (P> 0.05) (P <0.05). There was no significant difference in the positive rate of serum CA125 between stage Ⅰ and stage Ⅱ (P> 0.05). The serum levels of CA125 in stage Ⅲ and stage Ⅳ were significantly higher than those in stage Ⅰ and Ⅱ (P> 0.05). The positive rates of serum CA125 in stage Ⅲ and stage Ⅳ were significantly higher than those in stage Ⅰ and stage Ⅱ, and the difference was statistically significant (P <0.05). Conclusion: The stage of endometriosis has a certain correlation with the level of serum CA125. Serum CA125 in patients with stage Ⅲ and Ⅳ is highly sensitive, and the serum level of CA125 in evaluating the severity of endometriosis Has important reference value.